Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Simply Wealthy

<< Previous

Bullboard Posts

Next >>

Comment by jimsenioron Oct 21, 2022 2:26pm

156 Views

Post# 35039647

RE:RE:RE:RE:RE:Simply Wealthy

That is not my intention.

I mentioned simplywallstreet because their report is a material event in my opinion. I am not concerned with what simply seems to be concerned with.

I have always been long, am now long, and have never been short.

If we get a deal, I agree with the scenarios and examples you have put forth lo these many years.

My off the wall thought about a Pharma collaboration is not negative, just another way of looking at this, and highly unlikely.

If you still think I am pushing a negative narrative, well what more can I say. I thought your CEACAM6 explanation was excellent. Cheers.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec